Our study provides a comprehensive epigenetic profiling of AML, identifies new clinical markers for cases with a normal karyotype, and reveals relevant biological information related to the role of fusion proteins on the methylation signature.
Further analysis revealed that the only statistically significant marker for case fatality was MMP-8 (Table 3).
As shown in Figure 2, DDC is frequently overexpressed in poorly differentiated adenocarcinomas, suggesting that DDC is viable as a novel marker for cases that are undetectable with CEA.
However, several studies have reported that the frequency of anti-NCII might be as high as 60 75% in patients with RA when tested very early in the disease [ 14- 16], and thereafter frequencies tend to fall to those ascertained in the earlier cross-sectional studies [ 17], suggesting that their presence might provide a sensitive predictive marker for cases of early RA.
While the use of marker-sharing for case selection is only applicable to locus-specific sequencing, the sharing of markers among affected siblings can be used as part of the statistical analysis in genome-wide sequencing studies.
Molecular markers located on the Y chromosome are the most widely employed allogeneic markers for all cases of male DNA detection over high female background [Roewer, 2009].
Given the overlapping molecular features between subsets of type I and type II tumours, we sought to identify pathogenic factors and diagnostic markers for aggressive cases of endometrial carcinomas in general, irrespective of histological subtype.
To study whether miR-1, miR-133, and miR-206 could represent bona fide markers for DMD, a case-by-case correlation analysis between miRNA levels and North Star Ambulatory Assessment (NSAA, Mazzone et al, 2010) was performed in 10 ambulating young DMD children (age range between 3 and 6 years) at the time of the molecular diagnosis.
Scatter plots of BMI by inflammatory marker levels for cases and controls are presented in Supplementary Figure 1, see section on supplementary data given at the end of this article.
We controlled for a marker of case ascertainment in our model, but we may not have completely accounted for differences in case ascertainment across sites, and residual confounding due to unmeasured, spatially varying factors including other environmental exposures could affect our results.
